JPRN-UMIN000002137已完成1 期
PhaseI/II trial of neoadjvant chemoradiotherapy with docetaxel,CDDP and 5-Fluorouracil followed by surgery in patients with advanced esophageal cancer. - PhaseI/II trial of neoadjvant chemoradiotherapy with DCF in patients with advanced esophageal cancer.
Department of Surgical Oncology, Division of Clinical and Experimental Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University0 个研究点目标入组 40 人开始时间: 2009年8月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.History of hypersensitivity to DOC, CDDP, 5-FU, or polysorbate 80 2.With severe complication 3.Infection with fever elevation 4.Motor paralysis, peripheral neuropathy or edema 5.Pleural or pericardial effusion that requires treatment 6.Simultaneous or metachronous (within 5 years) double cancers. 7.Pregnant or lactating women 8.Interstitial pneumonia or fibroid lung 9.Psychosis
研究者
相似试验
已完成
1 期
Phase I trial of definitive chemoradiotherapy with paclitaxel, cisplatin, and 5-FU (PCF-RT) for esophageal canceresophageal cancerJPRN-UMIN000014927Aichi Cancer Center Hospital18
已完成
不适用
Phase II study of neoadjuvant chemoradiotherapy of s-1 and cisplatin for advanced gastric cancer with lymph node metastases (Neo-KOGC04 study)Advanced Gastric CancerJPRN-UMIN000014331School of Medicine, Keio University30
已完成
2 期
A phase II trial of definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) for advanced esophageal carcinoma (KDOG 0501 P2)locally advanced esophageal carcinomaJPRN-UMIN000002029Kitasato University School of Medicine35
已完成
1 期
Phase I/II trial of chemoradiotherapy concurrent with S-1 and cisplatin in patients with clinical stage II/III esophageal carcinoma (JCOG0604)JPRN-jRCT2091220010Japan Clinical Oncology Group(JCOG)81
未知
1 期
Phase I/II Study of Satraplatin Plus RadiotherapyJPRN-jRCT2080221482Yakult Honsha Co.,Ltd.33